These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges. Michel ML; Deng Q; Mancini-Bourgine M J Hepatol; 2011 Jun; 54(6):1286-96. PubMed ID: 21238516 [TBL] [Abstract][Full Text] [Related]
4. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever? Egan MA Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741 [No Abstract] [Full Text] [Related]
5. Progress on new vaccine strategies against chronic viral infections. Berzofsky JA; Ahlers JD; Janik J; Morris J; Oh S; Terabe M; Belyakov IM J Clin Invest; 2004 Aug; 114(4):450-62. PubMed ID: 15314679 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic vaccination in chronic hepatitis B virus carriers. Pol S; Michel ML Expert Rev Vaccines; 2006 Oct; 5(5):707-16. PubMed ID: 17181443 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic HIV vaccines show promise. Abbott A Nature; 2010 Jul; 466(7306):539. PubMed ID: 20671679 [No Abstract] [Full Text] [Related]
8. The global impact of vaccination against hepatitis B: a historical overview. Zanetti AR; Van Damme P; Shouval D Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855 [TBL] [Abstract][Full Text] [Related]
9. DNA vaccines for prophylactic or therapeutic immunization against hepatitis B. Michel ML; Loirat D Intervirology; 2001; 44(2-3):78-87. PubMed ID: 11509869 [TBL] [Abstract][Full Text] [Related]
10. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response. Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545 [TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus vaccines for the prevention and treatment of cervical cancer. Tomson TT; Roden RB; Wu TC Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 immunogen (remune). Newsline People AIDS Coalit N Y; 1998 Dec; ():36. PubMed ID: 11367099 [TBL] [Abstract][Full Text] [Related]
14. Current developments in viral DNA vaccines: shall they solve the unsolved? Rajcáni J; Mosko T; Rezuchová I Rev Med Virol; 2005; 15(5):303-25. PubMed ID: 15906276 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model. Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672 [TBL] [Abstract][Full Text] [Related]
16. [Present status of vaccines in 1989]. Roussey M; Dabadie A Pediatrie; 1989; 44(9):691-8. PubMed ID: 2560159 [TBL] [Abstract][Full Text] [Related]
17. Trial suggests vaccines could aid HIV therapy. Check E Nature; 2003 Apr; 422(6933):650. PubMed ID: 12700722 [No Abstract] [Full Text] [Related]
18. A boost for the immune system. TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365925 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic vaccination against HIV: current progress and future possibilities. Puls RL; Emery S Clin Sci (Lond); 2006 Jan; 110(1):59-71. PubMed ID: 16336205 [TBL] [Abstract][Full Text] [Related]
20. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]